HomepageBHC • NYSE
add
Bausch Health Companies Inc
$Â 5,44
Na sluitingstijd:(0,35%)+0,019
$Â 5,46
Gesloten: 25 apr, 16:40:01 GMT-4 · USD · NYSE · Disclaimer
Vorige slotkoers
$Â 5,48
Dag-range
$Â 5,32 - $Â 5,48
Jaar-range
$Â 3,96 - $Â 9,85
Beurswaarde
2,00Â mld. USD
Gem. volume
2,67Â mln.
Koers/winst
-
Dividendrendement
-
In het nieuws
Financiële informatie
Resultatenrekening
Opbrengst
Netto inkomsten
(USD) | dec 2024info | Wijziging j-o-j |
---|---|---|
Opbrengst | 2,56Â mld. | 6,27% |
Bedrijfskosten | 1,24Â mld. | 3,51% |
Netto inkomsten | 93,00Â mln. | 338,46% |
Netto winstmarge | 3,63 | 324,07% |
Winst per aandeel | 1,16 | -0,90% |
EBITDA | 901,00Â mln. | 7,78% |
Effectief belastingtarief | 53,11% | — |
Balans
Totale activa
Totale passiva
(USD) | dec 2024info | Wijziging j-o-j |
---|---|---|
Contanten en kortetermijnbeleggingen | 1,18Â mld. | 24,71% |
Totale activa | 26,52Â mld. | -3,02% |
Totale passiva | 26,84Â mld. | -2,14% |
Totaal aandelenvermogen | -322,00 mln. | — |
Uitstaande aandelen | 367,93 mln. | — |
Koers-boekwaardeverhouding | -1,57 | — |
Rendement op activa | 5,60% | — |
Rendement op kapitaal | 6,94% | — |
Kasstroom
Nettomutatie in liquide middelen
(USD) | dec 2024info | Wijziging j-o-j |
---|---|---|
Netto inkomsten | 93,00Â mln. | 338,46% |
Operationele kasstroom | 601,00Â mln. | 54,10% |
Kasstroom uit beleggingen | -200,00Â mln. | -35,14% |
Kasstroom uit financiering | 85,00Â mln. | 207,59% |
Nettomutatie in liquide middelen | 451,00Â mln. | 147,80% |
Vrije kasstroom | 362,62Â mln. | 504,38% |
Over
Bausch Health Companies Inc. is a global, diversified American-Canadian pharmaceutical company. Its global corporate headquarters are located in Laval, Quebec, Canada, and its U.S. headquarters are in Bridgewater, New Jersey. It develops, manufactures and markets a range of pharmaceutical products primarily in gastroenterology, hepatology, neurology, dermatology, dentistry, medical aesthetics, international pharmaceuticals and eye health, through controlling interest in Bausch + Lomb. Bausch Health's ambition is to be a globally integrated healthcare company, trusted and valued by patients, HCPs, employees and investors.
Bausch Health manufacture and market a broad range of branded and generic pharmaceuticals, and over-the-counter products directly or indirectly in more than 90 countries and regions, including the United States, Canada, Europe, the Middle East, Africa, Asia Pacific and Latin America. Wikipedia
CEO
Opgericht
1959
Hoofdvestiging
Website
Werknemers
20.700